Literature DB >> 21532230

Does a proton pump inhibitor cause hypokalemia?

Yoshitaka Maeda1, Naoki Kojima, Yuya Araki, Tomomi Uno, Keisuke Nishigaki, Naoto Inaba.   

Abstract

Proton pump inhibitors (PPIs) act only in the stomach, although the proton pump, H(+),K(+)-ATPase exists and contributes to H(+) and K(+) homeostasis in the kidney. We encountered two hypokalemic cases receiving omeprazole. These cases were women ages 69 and 80 years old. Their serum potassium levels decreased with accelerated urinary potassium excretion with the use of omeprazole, and recovered by potassium-supplement and the discontinuation of omeprazole. Because inhibitory effects of PPIs on H(+),K(+)-ATPase are exerted only in acidic condition, hypokalemia is not generally introduced by PPIs alone. However, in extreme alkalosis or impaired K(+)-recycling system, PPIs may cause hypokalemia unrelated to hypomagnesemia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21532230     DOI: 10.2169/internalmedicine.50.4877

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  5 in total

Review 1.  P2C-Type ATPases and Their Regulation.

Authors:  Rocío Retamales-Ortega; Carlos P Vio; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2015-01-29       Impact factor: 5.590

2.  Hypokalemia and hyperkalemia in patients on peritoneal dialysis: incidence and associated factors.

Authors:  Fernanda A Goncalves; Jessica Santos de Jesus; Lilian Cordeiro; Maria Clara T Piraciaba; Luiza K R P de Araujo; Carolina Steller Wagner Martins; Maria Aparecida Dalboni; Benedito J Pereira; Bruno C Silva; Rosa Maria A Moysés; Hugo Abensur; Rosilene M Elias
Journal:  Int Urol Nephrol       Date:  2020-02-03       Impact factor: 2.370

3.  Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis.

Authors:  Tigran Makunts; Isaac V Cohen; Linda Awdishu; Ruben Abagyan
Journal:  Sci Rep       Date:  2019-02-19       Impact factor: 4.379

4.  Electrolyte disturbances in children receiving omeprazole for gastroesophageal reflux disease.

Authors:  Fatemeh Famouri; Forough Derakhshani; Yahya Madihi; Armindokht Shahsanai
Journal:  J Res Med Sci       Date:  2020-11-26       Impact factor: 1.852

5.  Relationship between long-term use of proton pump inhibitor (PPI) and hypomagnesemia in patients with gastroesophageal reflux disease.

Authors:  Abbas Arj; Zeinab Ghaleh Takizadeh; Hamireza Gilassi; Mohsen Razavizadeh
Journal:  Caspian J Intern Med       Date:  2022
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.